Skip to main content
. 2019 Sep 11;19:328. doi: 10.1186/s12887-019-1713-2

Table 2.

Outcomes: Comparison between the Groups

Characteristics Male Female p-value
Mean (days) SD Mean (days) SD
LOS 57.3 34.3 54.1 30.3 0.428
Total ventilation 18.9 26.5 15.9 21.9 0.246
Invasive ventilation 9.7 18.7 8.6 16 0.578
O2 enrichment 25.6 31.3 23.8 27.3 0.585
Total N (%) Total N (%) p value
SRT 79 43 (54.4) 79 43 (54.4) 1.000
RDS 78 52 (66.7) 78 52 (66.7) 1.000
BPD 78 17 (21.8) 78 15 (19.2) 0.744
NEC 78 2 (2.6) 78 1 (1.3) 0.344
ROP 69 13 (18.8) 66 9 (13.6) 0.625
PVH/IVH 73 5 (6.8) 72 5 (6.9) 1.000
PVL 58 2 (3.4) 60 3 (5) 1.000
Early onset sepsis 78 3 (3.8) 78 0 (0) 0.250
Late onset sepsis 75 4 (5.3) 74 7 (9.5) 0.344
Mortality 79 9 (11.4) 79 11 (13.9) 0.727
Mean SD Mean SD p value
Outcome score 0.6 0.8 0.5 0.8 0.394

Total ventilation (days) includes nasal CPAP and invasive ventilation. Early onset sepsis refers to sepsis presenting in the first 72 h of life. Late onset sepsis refers to sepsis presenting after 72 h of life. Outcome score is a calculated score between 0 and 6, based on six parameters (mortality, BPD, NEC, ROP stages 2–4, PVH/IVH grades 3–4, PVL) with a weighted value of 0–1. BPD bronchopulmonary dysplasia, CPAP continuous positive airway pressure, LOS length of stay (hospitalization days), NEC – necrotizing enterocolitis, PVH/IVH periventricular/intraventricular hemorrhage grade 3–4, PVL periventricular leukomalacia, RDS respiratory distress syndrome, ROP retinopathy of prematurity stages 2–4, SD standard deviation, SRT surfactant replacement therapy